Cargando…

Establishment of Mouse Models of Psoriasis with Blood Stasis Syndrome Complicated with Glucose and Lipid Metabolism Disorders

BACKGROUND: Psoriasis has been reported as a high-risk factor for quality of life and survival rate in patients with metabolic disorder. However, there is no animal model for studying this disease. This study aimed to establish and evaluate mouse models of psoriasis with blood stasis syndrome (which...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Ying, Ru, Yi, Zhao, Huaibo, Liu, Liu, Hong, Seokgyeong, Sun, Xiaoying, Kuai, Le, Lu, Yi, Xing, Meng, Chen, Xi, Song, Jiankun, Luo, Yue, Fei, Xiaoya, Zhou, Yaqiong, Li, Hongjin, Li, Bin, Li, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875367/
https://www.ncbi.nlm.nih.gov/pubmed/31781274
http://dx.doi.org/10.1155/2019/6419509
_version_ 1783473014605611008
author Luo, Ying
Ru, Yi
Zhao, Huaibo
Liu, Liu
Hong, Seokgyeong
Sun, Xiaoying
Kuai, Le
Lu, Yi
Xing, Meng
Chen, Xi
Song, Jiankun
Luo, Yue
Fei, Xiaoya
Zhou, Yaqiong
Li, Hongjin
Li, Bin
Li, Xin
author_facet Luo, Ying
Ru, Yi
Zhao, Huaibo
Liu, Liu
Hong, Seokgyeong
Sun, Xiaoying
Kuai, Le
Lu, Yi
Xing, Meng
Chen, Xi
Song, Jiankun
Luo, Yue
Fei, Xiaoya
Zhou, Yaqiong
Li, Hongjin
Li, Bin
Li, Xin
author_sort Luo, Ying
collection PubMed
description BACKGROUND: Psoriasis has been reported as a high-risk factor for quality of life and survival rate in patients with metabolic disorder. However, there is no animal model for studying this disease. This study aimed to establish and evaluate mouse models of psoriasis with blood stasis syndrome (which is a key to psoriasis pathogenesis, according to Chinese Medicine) complicated with metabolic disorders. METHOD: Forty-five C57BL/6 mice were randomly divided into the blank control (Control), psoriasis (Imiquimod (IMQ)), psoriasis with metabolic disorders (IMQ + streptozotocin (STZ)), psoriasis with blood stasis syndrome (BSS) (IMQ + BSS), and psoriasis with blood stasis syndrome complicated with metabolic disorders (IMQ + STZ + BSS) groups (n = 9 mice/group). Psoriasis lesions were induced using IMQ cream (on both the ears and back, except in the Control group). Mice of the IMQ + BSS group were fed a half-fat, high-sugar diet and stimulated with ice-water swimming every day. Mice of the IMQ + STZ group were fed a half-fat, high-sugar diet and injected with STZ. Mice of the IMQ + STZ + BSS group were subjected to the same treatments as the IMQ + STZ and IMQ + BSS groups. After induction, the mice in each group were observed for vital signs, ear thickness, body weight, and psoriasis area and severity index (PASI) score. The mice were fasted for 12 h before determination of related laboratory serum indexes. Dorsal skin lesions, aortic arch pathology sections, and signal transducer and activator of transcription 3 (STAT3) were examined by H&E staining and immunohistochemistry. RESULTS: Laboratory indexes in the four model groups were significantly different from those in the Control group (p < 0.01); indicators of the IMQ + STZ, IMQ + BSS, and IMQ + STZ + BSS groups showed varying degrees of difference from those of the IMQ group. CONCLUSIONS: The established mouse models of psoriasis blood stasis syndrome complicated with glucose and lipid metabolism disorders met the clinical and Chinese Medicine characteristics, and thus they could be used as animal models in future studies of psoriasis complicated with glucose and lipid metabolism disorders.
format Online
Article
Text
id pubmed-6875367
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-68753672019-11-28 Establishment of Mouse Models of Psoriasis with Blood Stasis Syndrome Complicated with Glucose and Lipid Metabolism Disorders Luo, Ying Ru, Yi Zhao, Huaibo Liu, Liu Hong, Seokgyeong Sun, Xiaoying Kuai, Le Lu, Yi Xing, Meng Chen, Xi Song, Jiankun Luo, Yue Fei, Xiaoya Zhou, Yaqiong Li, Hongjin Li, Bin Li, Xin Evid Based Complement Alternat Med Research Article BACKGROUND: Psoriasis has been reported as a high-risk factor for quality of life and survival rate in patients with metabolic disorder. However, there is no animal model for studying this disease. This study aimed to establish and evaluate mouse models of psoriasis with blood stasis syndrome (which is a key to psoriasis pathogenesis, according to Chinese Medicine) complicated with metabolic disorders. METHOD: Forty-five C57BL/6 mice were randomly divided into the blank control (Control), psoriasis (Imiquimod (IMQ)), psoriasis with metabolic disorders (IMQ + streptozotocin (STZ)), psoriasis with blood stasis syndrome (BSS) (IMQ + BSS), and psoriasis with blood stasis syndrome complicated with metabolic disorders (IMQ + STZ + BSS) groups (n = 9 mice/group). Psoriasis lesions were induced using IMQ cream (on both the ears and back, except in the Control group). Mice of the IMQ + BSS group were fed a half-fat, high-sugar diet and stimulated with ice-water swimming every day. Mice of the IMQ + STZ group were fed a half-fat, high-sugar diet and injected with STZ. Mice of the IMQ + STZ + BSS group were subjected to the same treatments as the IMQ + STZ and IMQ + BSS groups. After induction, the mice in each group were observed for vital signs, ear thickness, body weight, and psoriasis area and severity index (PASI) score. The mice were fasted for 12 h before determination of related laboratory serum indexes. Dorsal skin lesions, aortic arch pathology sections, and signal transducer and activator of transcription 3 (STAT3) were examined by H&E staining and immunohistochemistry. RESULTS: Laboratory indexes in the four model groups were significantly different from those in the Control group (p < 0.01); indicators of the IMQ + STZ, IMQ + BSS, and IMQ + STZ + BSS groups showed varying degrees of difference from those of the IMQ group. CONCLUSIONS: The established mouse models of psoriasis blood stasis syndrome complicated with glucose and lipid metabolism disorders met the clinical and Chinese Medicine characteristics, and thus they could be used as animal models in future studies of psoriasis complicated with glucose and lipid metabolism disorders. Hindawi 2019-11-12 /pmc/articles/PMC6875367/ /pubmed/31781274 http://dx.doi.org/10.1155/2019/6419509 Text en Copyright © 2019 Ying Luo et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Luo, Ying
Ru, Yi
Zhao, Huaibo
Liu, Liu
Hong, Seokgyeong
Sun, Xiaoying
Kuai, Le
Lu, Yi
Xing, Meng
Chen, Xi
Song, Jiankun
Luo, Yue
Fei, Xiaoya
Zhou, Yaqiong
Li, Hongjin
Li, Bin
Li, Xin
Establishment of Mouse Models of Psoriasis with Blood Stasis Syndrome Complicated with Glucose and Lipid Metabolism Disorders
title Establishment of Mouse Models of Psoriasis with Blood Stasis Syndrome Complicated with Glucose and Lipid Metabolism Disorders
title_full Establishment of Mouse Models of Psoriasis with Blood Stasis Syndrome Complicated with Glucose and Lipid Metabolism Disorders
title_fullStr Establishment of Mouse Models of Psoriasis with Blood Stasis Syndrome Complicated with Glucose and Lipid Metabolism Disorders
title_full_unstemmed Establishment of Mouse Models of Psoriasis with Blood Stasis Syndrome Complicated with Glucose and Lipid Metabolism Disorders
title_short Establishment of Mouse Models of Psoriasis with Blood Stasis Syndrome Complicated with Glucose and Lipid Metabolism Disorders
title_sort establishment of mouse models of psoriasis with blood stasis syndrome complicated with glucose and lipid metabolism disorders
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875367/
https://www.ncbi.nlm.nih.gov/pubmed/31781274
http://dx.doi.org/10.1155/2019/6419509
work_keys_str_mv AT luoying establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT ruyi establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT zhaohuaibo establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT liuliu establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT hongseokgyeong establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT sunxiaoying establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT kuaile establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT luyi establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT xingmeng establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT chenxi establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT songjiankun establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT luoyue establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT feixiaoya establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT zhouyaqiong establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT lihongjin establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT libin establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders
AT lixin establishmentofmousemodelsofpsoriasiswithbloodstasissyndromecomplicatedwithglucoseandlipidmetabolismdisorders